. Study finds high prevalence of drug interactions in adults taking Paxlovid - IOPAC Press "Enter" to skip to content

WHO Results Report 2023 shows notable health achievements and calls for concerted drive toward Sustainable Development Goals
- All WHO news
<p>The World Health Organization (WHO) <a href="https://www.who.int/about/accountability/results/who-results-report-2022-2023">Results Report 2023</a>, the most comprehensive to date, showcases achievement of key public health...
Rafah incursion would substantially increase mortality and morbidity and further weaken an already broken health system
- All WHO news
WHO is deeply concerned that a full-scale military operation in Rafah could lead to a bloodbath. More than 1.2 million...
Governments near agreement on package of amendments to the International Health Regulations (2005)
- All WHO news
In the eighth meeting of the Working Group on Amendments to the International Health Regulations (WGIHR), which was suspended yesterday...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Study finds high prevalence of drug interactions in adults taking Paxlovid

By iopac on October 21, 2023

The real-world findings underscore the need to manage drug interactions in patients treated with Paxlovid.

Published in COVID-19

iopac